Identity
Testing confirms the compound is the peptide listed on the vial, not just a lookalike or mislabeled powder.
Every Novo+ product is tied to batch-level documentation. The goal is simple: customers should be able to see what was tested, when it was tested, and how the result connects to the vial they receive.


Testing confirms the compound is the peptide listed on the vial, not just a lookalike or mislabeled powder.
Chromatography checks for the main peptide peak and flags unwanted impurities that should not be present at release.
Batch review verifies the amount in the vial aligns with the labeled strength and expected concentration.
A product is cleared for sale only after documentation matches the product, batch, and internal quality threshold.
A COA should connect a real test result to a real batch. If the document cannot be matched to the vial, it does not answer the most important quality question.
A COA without a batch number
A product page that shows one generic certificate for every strength
No test date, no method, or no lab information
A purity claim that cannot be tied back to the vial being shipped